Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 2
2014 2
2018 1
2019 5
2020 4
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

12 results
Results by year
Filters applied: . Clear all
Page 1
Obesity worsens central inflammation and disability in multiple sclerosis.
Stampanoni Bassi M, Iezzi E, Buttari F, Gilio L, Simonelli I, Carbone F, Micillo T, De Rosa V, Sica F, Furlan R, Finardi A, Fantozzi R, Storto M, Bellantonio P, Pirollo P, Di Lemme S, Musella A, Mandolesi G, Centonze D, Matarese G. Stampanoni Bassi M, et al. Among authors: sica f. Mult Scler. 2020 Sep;26(10):1237-1246. doi: 10.1177/1352458519853473. Epub 2019 Jun 4. Mult Scler. 2020. PMID: 31161863
Cerebrospinal fluid inflammatory biomarkers predicting interferon-beta response in MS patients.
Stampanoni Bassi M, Drulovic J, Pekmezovic T, Iezzi E, Sica F, Gilio L, Gentile A, Musella A, Mandolesi G, Furlan R, Finardi A, Marfia GA, Bellantonio P, Fantozzi R, Centonze D, Buttari F. Stampanoni Bassi M, et al. Among authors: sica f. Ther Adv Neurol Disord. 2020 Dec 8;13:1756286420970833. doi: 10.1177/1756286420970833. eCollection 2020. Ther Adv Neurol Disord. 2020. PMID: 33343708 Free PMC article.
IL-6 in the Cerebrospinal Fluid Signals Disease Activity in Multiple Sclerosis.
Stampanoni Bassi M, Iezzi E, Drulovic J, Pekmezovic T, Gilio L, Furlan R, Finardi A, Marfia GA, Sica F, Centonze D, Buttari F. Stampanoni Bassi M, et al. Among authors: sica f. Front Cell Neurosci. 2020 Jun 23;14:120. doi: 10.3389/fncel.2020.00120. eCollection 2020. Front Cell Neurosci. 2020. PMID: 32655367 Free PMC article.
Interleukin-6 Disrupts Synaptic Plasticity and Impairs Tissue Damage Compensation in Multiple Sclerosis.
Stampanoni Bassi M, Iezzi E, Mori F, Simonelli I, Gilio L, Buttari F, Sica F, De Paolis N, Mandolesi G, Musella A, De Vito F, Dolcetti E, Bruno A, Furlan R, Finardi A, Marfia GA, Centonze D, Rizzo FR. Stampanoni Bassi M, et al. Among authors: sica f. Neurorehabil Neural Repair. 2019 Oct;33(10):825-835. doi: 10.1177/1545968319868713. Epub 2019 Aug 20. Neurorehabil Neural Repair. 2019. PMID: 31431121
Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders.
Novi G, Bovis F, Capobianco M, Frau J, Mataluni G, Curti E, Zuliani L, Cavalla P, Brambilla L, Annovazzi P, Repice AM, Lanzillo R, Esposito S, Benedetti L, Maietta I, Sica F, Buttari F, Malucchi S, Fenu G, Landi D, Bosa C, Realmuto S, Malentacchi M, Granella F, Signori A, Bonavita S, Uccelli A, Sormani MP; iMUST group. Novi G, et al. Among authors: sica f. Mult Scler Relat Disord. 2019 Nov;36:101430. doi: 10.1016/j.msard.2019.101430. Epub 2019 Oct 4. Mult Scler Relat Disord. 2019. PMID: 31610404
Fingolimod reduces the clinical expression of active demyelinating lesions in MS.
Signoriello E, Landi D, Monteleone F, Saccà F, Nicoletti CG, Buttari F, Sica F, Marfia GA, Di Iorio G, Lus G, Centonze D. Signoriello E, et al. Among authors: sica f. Mult Scler Relat Disord. 2018 Feb;20:215-219. doi: 10.1016/j.msard.2018.02.002. Epub 2018 Feb 5. Mult Scler Relat Disord. 2018. PMID: 29433094
12 results